Everything You Need to Know About Imaging Analytics For Clinical Trials
The image acquisition and analysis components of R&D and clinical trials can be quite complex...
Do Oncology Clinical Trials Need PR?
Designing protocols to maintain a trial's validity while enabling seriously ill and informed participants to receive both SOC and investigational products will help to improve patient participation in oncology clinical trials.
ICON Selected by the FDA for New PRO Measure
ICON announced it has been awarded a project by the FDA to develop an industry-standard Patient Reported Outcome
Clinverse Inc. and ACRES Announce Strategic Partnership
Clinverse, Inc. and the Alliance for Clinical Research Excellence and Safety announced today that they have formed a strategic partnership.
ICON Selected by the FDA to Develop New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial PneumoniaTrials
New PRO measure being developed in conjunction with the FNIH Biomarkers Consortium
Helping Patients in Patient-Centered Approaches to Health
Growing insistence on making healthcare more patient-centered is generating a new level of interest in helping patients to meet the expectations the new orthodoxy is creating.
ERT Acquires eClinical Insights
ERT announced the acquisition of eClinical Insights
New Republican Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
The 2014 mid-term elections handed over control of the Senate to Republicans and boosted the GOP majority in the House.
Clinverse, ACRES Announce Strategic Partnerships
Clinverse and ACRES announced a strategic alliance.
ERT Announces Acquisition of eClinical Insights
Combined Offering Enables Real Time Decision Making in Global Clinical Trials
The Strategy Behind LabCorp's Acquisition of Covance
Here is a summary of what analysts are saying about LabCorp's purchase of Covance.
Tufts CSDD: CNS Drugs Longer to Develop; Lower Success Rates
Drugs that treat central nervous system diseases take more than a year longer to develop and are less than half as likely to obtain marketing approval
Medidata and PPD Partner to Offer New Approach to Risk-Based Monitoring
Joint Effort to Enable Faster, Safer and Smarter Clinical Trial Reviews for Life Science Industry
OPKO Health Selects DSG's eCaseLink
OPKO has selected DSG?s eCaseLink integrated suite
New Clincial Trials Regulation: Driving Transparency and Stimulating Innovation in Europe EUCROF releases its Position Paper on Transparency in Early Phase Clinical Research
EUCROF released proposals on the early publication of clinical trial information, balancing the public's need for transparency and innovators' intellectual property and confidentiality rights.
DSG and OPKO Health Enter into Enterprise Licensing Agreement for Fully Integrated EDC, Safety, and Trial Management Solution
OPKO Health to build and configure integrated data capture and drug safety systems
CNS Drugs Take Longer to Develop and Have Lower Success Rates than Other Drugs, According to the Tufts Center for the Study of Drug Development
Drugs that treat central nervous system diseases take more than a year longer to develop
EUCROF Releases Position Paper on Research Transparency
EUCROF has unveiled proposals on the early publication of clinical trial information.
Medidata and PPD announced they are expanding their partnership around risk-based monitoring.
Early Phase Clinical Trials: Public Access to the EU Database Repository
This position paper has been prepared by the European Contract Research Organisation Federation (EUCROF).
LabCorp to Acquire Covance
LabCorp and Covance have entered into a definitive agreement
Who's in Charge of Medicines in Brussels?
So now we know who is to do what on health issues in the new European Commission. Or do we?
LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World's Leading Healthcare Diagnostics Company
Covance shareholders to receive cash and LabCorp shares currently valued at $105.12 per Covance share
Re-imagining Research May Need an Attitude Adjustment
We hear it all the time these days: research processes have to undergo transformative changes in order for research organizations to thrive?or even survive.
New Research Strategies Proposed for Developing Antibiotics
There's a mounting campaign to encourage biopharmaceutical companies to develop new therapies to treat drug-resistant infections.
Large-scale Deployment of Velos Investigational Drug System Goes Live
Velos recently activated its Investigational Drug System at The University of Texas MD Anderson Cancer Center
Text Messaging: Enhancing Clinical Trial Patient Recruitment and Enrollment
There is a lot of new research that evaluates the impact of Short Messaging System (SMS, Text Messages) in healthcare settings.
Velos' IND Accountability System Implemented at MD Anderson Cancer Center
Over 100 MD Anderson pharmacists and technicians across 15 dispensing pharmacies began using the Velos Internet-based software
Oncology Trials Are Taking Longer
KMR Group has recently assessed the duration of oncology trials.
Oncology Trial Times On the Increase
KMR Group recently assessed the duration of oncology trials and found a steady rise
